Crinetics Pharmaceuticals, Inc.
CRNXDelisted Sep 1, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Crinetics Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 140
- +11 vs. Q1 2023
- Shares held
- 54.1M
- −1.00M (−1.8%) vs. Q1 2023
- Total value
- $974.1M
- +$89.8M (+10.2%) vs. Q1 2023
- New holders
- 27
- 56 more added
- Sold out
- 16
- 33 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $4.63B |
| Q1 2026 | 244 | $4.46B |
| Q4 2025 | 242 | $5.20B |
| Q3 2025 | 225 | $4.49B |
| Q2 2025 | 222 | $3.01B |
| Q1 2025 | 227 | $3.42B |
| Q4 2024 | 247 | $5.10B |
| Q3 2024 | 235 | $4.32B |
| Q2 2024 | 234 | $3.69B |
| Q1 2024 | 203 | $3.76B |
| Q4 2023 | 181 | $2.51B |
| Q3 2023 | 172 | $2.04B |
| Q2 2023 | 140 | $974.1M |
| Q1 2023 | 129 | $884.3M |
| Q4 2022 | 122 | $1.00B |
| Q3 2022 | 122 | $1.01B |
| Q2 2022 | 111 | $944.5M |
| Q1 2022 | 116 | $997.4M |
| Q4 2021 | 118 | $1.26B |
| Q3 2021 | 94 | $708.2M |
| Q2 2021 | 83 | $616.9M |
| Q1 2021 | 80 | $465.3M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Crinetics Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 225,000 | $4.05M | 0.01% | +225,000 | New |
| Citadel Advisors LLC | 241,728 | $4.36M | 0.00% | −43,867−15.4% | Reduced |
| Ensign Peak Advisors, Inc | 270,269 | $4.87M | 0.01% | 00.0% | Unchanged |
| Walleye Capital LLC | 313,598 | $5.65M | 0.10% | −120,097−27.7% | Reduced |
| Nuveen Asset Management, LLC | 343,179 | $6.18M | 0.00% | +218,870+176.1% | Added |
| Charles Schwab Investment Management Inc | 350,738 | $6.32M | 0.00% | +5,171+1.5% | Added |
| Eventide Asset Management, LLC | 434,768 | $7.83M | 0.13% | 00.0% | Unchanged |
| Jennison Associates LLC | 461,497 | $8.32M | 0.01% | +461,497 | New |
| Bank of New York Mellon Corp | 463,418 | $8.35M | 0.00% | +40,629+9.6% | Added |
| Janus Henderson Group PLC | 470,736 | $8.48M | 0.01% | +54,484+13.1% | Added |
| Ikarian Capital, LLC | 475,000 | $8.56M | 3.02% | +475,000 | New |
| MPM Oncology Impact Management LP | 479,053 | $8.63M | 1.74% | +118,661+32.9% | Added |
| Northern Trust Corp | 490,730 | $8.84M | 0.00% | +13,442+2.8% | Added |
| Dimensional Fund Advisors LP | 519,109 | $9.35M | 0.00% | +69,504+15.5% | Added |
| GW&K Investment Management, LLC | 585,740 | $10.6M | 0.10% | +48,860+9.1% | Added |
| Goldman Sachs Group Inc | 614,846 | $11.1M | 0.00% | +94,648+18.2% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 641,345 | $11.6M | 0.04% | −49,856−7.2% | Reduced |
| Braidwell LP | 650,312 | $11.7M | 0.38% | −1,369,402−67.8% | Reduced |
| Morgan Stanley | 746,159 | $13.4M | 0.00% | +93,243+14.3% | Added |
| Finepoint Capital LP | 797,527 | $14.4M | 4.97% | −70,900−8.2% | Reduced |
| Opaleye Management Inc. | 845,000 | $15.2M | 3.64% | +59,206+7.5% | Added |
| 5AM Venture Management, LLC | 862,286 | $15.5M | 3.87% | 00.0% | Unchanged |
| Saturn V Capital Management LLC | 938,677 | $16.9M | 9.38% | +197,634+26.7% | Added |
| T. Rowe Price Investment Management, Inc. | 964,005 | $17.4M | 0.01% | +34,636+3.7% | Added |
| Geode Capital Management, LLC | 987,490 | $17.8M | 0.00% | +32,630+3.4% | Added |
| FMR LLC | 1,082,914 | $19.5M | 0.00% | +161,956+17.6% | Added |
| Novo Holdings A/S | 1,100,000 | $19.8M | 1.53% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 1,330,263 | $24.0M | 0.63% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 1,395,002 | $25.1M | 2.03% | +261,220+23.0% | Added |
| Frazier Life Sciences Management, L.P. | 1,414,823 | $25.5M | 1.52% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,428,910 | $25.8M | 0.00% | +1,387,127+3,319.8% | Added |
| First Light Asset Management, LLC | 1,557,222 | $28.1M | 2.20% | −61,903−3.8% | Reduced |
| Perceptive Advisors LLC | 1,946,937 | $35.1M | 1.02% | −1,607,950−45.2% | Reduced |
| State Street Corp | 2,237,735 | $40.3M | 0.00% | +18,941+0.9% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $41.5M | 4.28% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,732,734 | $49.2M | 0.00% | +39,672+1.5% | Added |
| Wellington Management Group LLP | 3,601,712 | $64.9M | 0.01% | −33,814−0.9% | Reduced |
| OrbiMed Advisors LLC | 3,950,796 | $71.2M | 1.39% | 00.0% | Unchanged |
| BlackRock Inc. | 4,600,486 | $82.9M | 0.00% | +644,128+16.3% | Added |
| Driehaus Capital Management LLC | 5,298,088 | $95.5M | 1.21% | +8,569+0.2% | Added |
| BVF Inc | 0 | $0 | 0.00% | −2,736,613−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −226,400−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −82,747−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −73,890−100.0% | Sold out |
| Westwood Holdings Group Inc. | 0 | $0 | 0.00% | −28,402−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −26,166−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −18,710−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −12,886−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −12,703−100.0% | Sold out |
| Bourgeon Capital Management LLC | 0 | $0 | 0.00% | −4,150−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −192−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | 0 | Sold out |